ZIMBABWE yesterday launched the rollout of Lenacapavir in Epworth, a groundbreaking twice-yearly injectable drug designed to slash new HIV infections.The long-acting pre-exposure prophylaxis (PrEP) represents a massive leap in medical technology, offering six months of protection with a single shot.Authorities believe this discreet method would solve the adherence challenges associated with daily pills, particularly for…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions